Affiliation:
1. School of Pharmacy at Fukuoka , International University of Health and Welfare , Okawa-City , Fukuoka , Japan
2. The Ministry of Justice in Japan , Correction Bureau , Tokyo , Japan
Abstract
Abstract
Objectives
Chronic pain is defined as pain that persists or recurs for more than 3 months. This study focuses on neuropathic pain (NP) and fibromyalgia (FM) which are chronic pain states, and aims to identify lifestyle habits associated with their prevalence. Other neurological disorders are also analyzed as references.
Methods
Association between the variable referring to disease prevalence (number of claims for reimbursement of marker drugs) and the variable for lifestyle habits/health examination results (collected from insured individuals aged 40–74 years) was determined by analyzing Japanese nationwide datasets, which were collected in 2018 and aggregated by prefecture. Pregabalin, donepezil, and levodopa were used as marker drugs for the chronic pain states, dementia-related diseases (Alzheimer’s disease and Lewy body dementia) and Parkinson’s disease (PD), respectively. Pearson’s correlation analysis and multiple linear regression analysis were conducted.
Results
Variables showing correlation coefficient (|r|)>0.5 were put into the multiple linear regression. Exercise habits (ꞵ=−0.3182), smoking habits (0.3218), daily drinking (0.2683), and alanine aminotransferase>51 U/L (0.2309) were finally incorporated in the equation for pregabalin (R
2=0.7268). Walking speed (−0.4543) and daily drinking (0.5077) were incorporated in the equation for donepezil (R
2=0.5718).
Conclusions
The prevalence of chronic pain states is associated with lifestyle habits, just like the dementia-related diseases. Exercise in daily life is negatively associated with the prevalence of the chronic pain states, although excessive alcohol drinking, smoking, and high serum ALT are positively associated with it. The prevalence of PD seems less associated with lifestyle habits.
Subject
Anesthesiology and Pain Medicine,Neurology (clinical)
Reference50 articles.
1. MHLW Japan. The 5th NDB open data; 2020. Available from: https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/0000177221_00008.html.
2. MHLW Japan. The 6th NDB open data; 2021. Available from: https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/0000177221_00010.html.
3. Nagakura, Y, Hayashi, M, Kajioka, S. Lifestyle habits to prevent the development of benign prostatic hyperplasia: analysis of Japanese nationwide datasets. Prostate Int 2022;10:200–6. https://doi.org/10.1016/j.prnil.2022.06.004.
4. Treede, RD, Rief, W, Barke, A, Aziz, Q, Bennett, MI, Benoliel, R, et al.. Chronic pain as a symptom or a disease: the IASP classification of chronic pain for the international classification of diseases (ICD-11). Pain 2019;160:19–27. https://doi.org/10.1097/j.pain.0000000000001384.
5. Treede, RD, Jensen, TS, Campbell, JN, Cruccu, G, Dostrovsky, JO, Griffin, JW, et al.. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology 2008;70:1630–5. https://doi.org/10.1212/01.wnl.0000282763.29778.59.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献